Fera Development, LLC   Report issue

For profit Phase 2
Founded: Locust Valley NY United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2013
NCT01860664
First Marketed Drug
2010
echothiophate (phospholine iodide)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

FERA PHARMS | FERA PHARMS LLC | Fera Science | Fera Science Ltd.